ZB
ABMD

Zions Bancorporation’s Abiomed Inc ABMD Stock Holding History

Zions Bancorporation’s Portfolio ABMD Stock Details ABMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-1,117
Closed -$274K – 1102
2022
Q3 		$274K Buy
1,117
+56
+5% +$15.1K 0.03% 277
2022
Q2 		$263K Buy
1,061
+201
+23% +$54.2K 0.03% 291
2022
Q1 		$285K Buy
860
+852
+10,650% +$262K 0.03% 290
2021
Q4 		$3K Sell
8
-3
-27% -$1.01K ﹤0.01% 915
2021
Q3 		$4K Buy
11
+2
+22% +$678 ﹤0.01% 871
2021
Q2 		$3K Hold
9
– – ﹤0.01% 901
2021
Q1 		$3K Sell
9
-16
-64% -$5.12K ﹤0.01% 869
2020
Q4 		$8K Buy
25
+3
+14% +$830 ﹤0.01% 732
2020
Q3 		$6K Hold
22
– – ﹤0.01% 799
2020
Q2 		$5K Buy
+22
New +$4.42K ﹤0.01% 760
2020
Q1 		– Sell
-16
Closed -$3K – 1022
2019
Q4 		$3K Buy
+16
New +$2.97K ﹤0.01% 859
2018
Q4 		– Sell
-6
Closed -$3K – 799
2018
Q3 		$3K Buy
+6
New +$2.37K ﹤0.01% 690
2017
Q4 		– Sell
-1,461
Closed -$246K – 1015
2017
Q3 		$246K Buy
+1,461
New +$221K 0.04% 232

Other funds holding ABMD

TRSOTSOK
Teachers Retirement System of the State of Kentucky Frankfort, Kentucky $12.9B AUM 31.03% 1-Year Est. Return
BTI
Blue Trust Inc Alpharetta, Georgia $8.74B AUM 14.62% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return
Rockefeller Capital Management
Rockefeller Capital Management New York $56.4B AUM 24.96% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $4.82B AUM 20.19% 1-Year Est. Return
AW
Avion Wealth The Woodlands, Texas $484M AUM 15.17% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Zions Bancorporation's ABMD Position: Q4 2022 in Review

Zions Bancorporation sold out of Abiomed Inc (ABMD) in Q4 2022, closing a stake of 1,117 shares — an estimated $274K sold.

Zions Bancorporation first reported a position in ABMD in Q3 2017 and held it in 13 quarters. The position peaked at $285K in Q1 2022. 8 funds tracked by Wall St. Rank hold ABMD as of Q4 2022.

  • Zions Bancorporation reported no remaining Abiomed Inc position as of Q4 2022 after selling out during the quarter.
  • Zions Bancorporation sold 1,117 Abiomed Inc shares in Q4 2022, an estimated $274K.
  • Zions Bancorporation first reported a position in Abiomed Inc in Q3 2017 and held it in 13 quarters.
  • Zions Bancorporation's Abiomed Inc position peaked at $285K in Q1 2022.
  • 8 funds tracked by Wall St. Rank held Abiomed Inc as of Q4 2022.

Based on Zions Bancorporation's 13F filing for Q4 2022, filed 10 Feb 2023.